Metraipolis › archive › dc_b2d07c2d8eb8
Targeting PFKFB3 to enhance CDK4/6 inhibitor response in ER+ breast cancer — Europe PMC PMID:42343408
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42343408
- DOI
- 10.1186/s13058-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T08:51:22.961Z
- SHA-256 of the archived text
e4804ff92a11b26788b2c8ea52d341df0f435331adfa460fb0c8048c057080b2- Stable URL of this page
https://metraipolis.com/documento/dc_b2d07c2d8eb8
How to cite
Targeting PFKFB3 to enhance CDK4/6 inhibitor response in ER+ breast cancer — Europe PMC PMID:42343408 — Europe PMC (en), https://europepmc.org/article/MED/42343408 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b2d07c2d8eb8 (Metraipolis archive dc_b2d07c2d8eb8, sha256 e4804ff92a11b26788b2c8ea52d341df0f435331adfa460fb0c8048c057080b2)
BibTeX
@misc{dcb2d07c2d8eb8,
title = {Targeting PFKFB3 to enhance CDK4/6 inhibitor response in ER+ breast cancer — Europe PMC PMID:42343408},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42343408},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b2d07c2d8eb8; sha256 e4804ff92a11b26788b2c8ea52d341df0f435331adfa460fb0c8048c057080b2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42343408. Agents can read the archived copy with the MCP tool read_document.